Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naïve emergency department patients

Clinical Chemistry

Volumn 52, Issue 11, 2006, Pages 2028-2035

  Kavsak, Peter A ^a,f   MacRae, Andrew R ^b   Palomaki, Glenn E ^d   Newman, Alice M ^c   Ko, Dennis T ^c   Lustig, Viliam ^b   Tu, Jack V ^c   Jaffe, Allan S ^e  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d WOMEN AND INFANTS HOSPITAL   (United States)

^e MAYO CLINIC   (United States)

^f MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DEVICE; EMERGENCY WARD; FEMALE; HEART DEATH; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; OUTCOMES RESEARCH; RETROSPECTIVE STUDY; SURVIVAL RATE; WORLD HEALTH ORGANIZATION;

AGED; AMERICAN HEART ASSOCIATION; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE-FREE SURVIVAL; EMERGENCY SERVICE, HOSPITAL; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ONTARIO; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TROPONIN I; WORLD HEALTH ORGANIZATION;

EID: 33750451246     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.073403     Document Type: Article

References (23)

1. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-69.
2. Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, et al. AHA Scientific Statement. Case definitions for acute coronary heart disease in epidemiology and clinical research studies. Circulation 2003;108:2543-9.
3. Lin JC, Apple FS, Murakami MM, Luepker RV. Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes. Clin Chem 2004;50:333-8.
4. Trevelyan J, Needham EW, Smith SC, Mattu RK. Impact of the recommendations for the redefinition of myocardial infarction on diagnosis and prognosis in an unselected United Kingdom cohort with suspected cardiac chest pain. Am J Cardiol 2004;93:817-21.
5. Salomaa V, Koukkunen H, Ketonen M, Immonen-Raiha P, Karja-Koskenkari P, Mustonen J, et al. A new definition for myocardial infarction: what difference does it make? Eur Heart J 2005;26:1719-25.
6. Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury. Can Med Assoc J 2005;173:1191-202.
7. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology Consensus Recommendations. Clin Chem 2003;49:1331-6.
8. Kavsak PA, MacRae AR, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, et al. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J 2006;152:118-25.
9. MacRae AR, Kavsak PA, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, et al. Assessing the Requirement for the 6-hour interval between specimens in the American Heart Association classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. Clin Chem 2006;52:812-8.
10. Venge P, Lindahl B, Wallentin L. New generation cardiac troponin I assay for the access immunoassay system. Clin Chem 2001;47:959-61.
11. Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004;50:2279-85.
12. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32.
13. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-21.
14. Apple FS, Parvin CA, Buechler KF, Christenson RH, Wu AH, J Jaffe AS. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem 2005;51:2198-200.
15. Austin PC, Daly PA, Tu JV. A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J 2002;144:290-6.
16. Furman MI, Dauerman HL, Goldberg RJ, Yarzebski J, Lessard D, Gore JM. Twenty-two year (1975 to 1997) Trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol 2001;37:1571-80.
17. Armstrong PW, Fu Y, Chang WC, Topol EJ, Granger CB, Betriu A, et al. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. Circulation 1998;98:1860-8.
18. Kontos MS, Shah R, Fritz LM, Anderson FP, Tatum JL, Ornato JP, et al. Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol 2004;43:958-65.
19. Sabatine MS, Morrow DA, McCabe CH, Antman EM, Gibson CM, Cannon CP. Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction. Am Heart J 2006;151:25-31.
20. Morrow DA, Rifai N, Sabatine MS, Ayanian S, Murphy SA, de Lemos JA, et al. Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes. Clin Chem 2003;49:1396-8.
21. Kavsak P, Lustig V, MacRae AR. Clinical evaluation of the Beckman Coulter AccuTnI assay for the early detection of acute myocardial infarction [Abstract]. Clin Chem 2004;50:A5.
22. Geltman EM, Ehsani AA, Campbell MK, Schechtman K, Roberts R, Sobel BE. The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation 1979;60:805-14.
23. Alexander JH, Sparapani RA, Mahaffey KW, Deckers JW, Newby LK, Ohman EM, et al. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. JAMA 2000;283:347-53.